ReviewCureus2025
Efficacy of Dietary Interventions in Managing Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes and Gut Microbiota Modulation.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Randomized Controlled Trial Comparing Low-FODMAP and Gluten-Free Diets on Gastrointestinal Symptoms, Nutritional Status, and Quality of Life in Irritable Bowel Syndrome.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Article
- Advances in understanding intestinal microbiota mechanisms and intervention strategies for anxiety, depression, sleep disorders, and constipation.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review explores the effectiveness of dietary interventions in the management of irritable bowel syndrome (IBS), focusing on clinical outcomes and gut microbiota modulation. A broad search of medical literature identified several high-quality studies examining dietary approaches such as low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diets, gluten-free regimens, and fiber supplementation. Across the included studies, these interventions were consistently associated with reductions in symptom severity and improvements in quality of life (QOL). In addition, several dietary strategies contributed to favorable changes in gut microbial composition, supporting the role of diet in influencing underlying mechanisms of IBS. Tailored interventions that accounted for individual food sensitivities or triggers demonstrated greater clinical benefit and adherence. Overall, the findings emphasize the potential of personalized dietary modifications as a cornerstone of IBS management. However, further investigation is needed to evaluate long-term outcomes, sustainability, and cost-effectiveness of these approaches across varied patient populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.